Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2132

Yorvipath’s approval showcases biopharma’s interest in rare endocrine disorder

$
0
0
Michele Rayes used to take 64 pills a day to manage her hypoparathyroidism, a rare endocrine disorder that impairs calcium levels, dampens daily quality of life and can sometimes lead to chronic kidney disease. ...

Viewing all articles
Browse latest Browse all 2132

Trending Articles